Justice Department Briefing 2026-04-24
Estimated reading time: 5 minutes
1. Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I
Sub: Justice Department, Drug Enforcement Administration
Content: With the issuance of this final rule, the Drug Enforcement Administration places methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H- indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. This action imposes regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle MDMB-4en-PINACA.
2. United States et al. v. Constellation Energy Corporation, Inc. et al. Response of Plaintiff United States to Public Comments on the Proposed Final Judgment
Sub: Justice Department, Antitrust Division
Legal Disclaimer
This article includes content collected from the Federal Register (federalregister.gov). The content is not an official government publication. This article is for informational purposes only and does not constitute legal advice. For case-specific consultation, please
contact us.
Read our full Legal Disclaimer, which also includes information on translation accuracy.
